Related Experiment Video
Updated: Jul 15, 2026

Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Oral contraceptive discontinuation: do side effects matter?
Carolyn L Westhoff1, Stephen Heartwell, Sharon Edwards
1Department of Obstetrics and Gynecology, Columbia University Medical Center/New York Presbyterian Hospital, and the Mailman School of Public Health, Columbia University, New York, NY, USA. clw3@columbia.edu
Objective:
The purpose of this study was to assess self-reported side effects in women after they received the oral contraceptive (OC) and to compare discontinuation rates, according to presence or absence of side effects.
Study Design:
The study comprised 1716 women aged <25 years who initiated the OC at 3 publicly funded family planning clinics and completed structured interviews after 3 and 6 months.
Results:
Nearly 60% of subjects discontinued the OC by 6 months. Most subjects reported no changes in headaches, weight, moodiness, and sexual satisfaction during the first 3 months of OC use. Subjects with any complaints, especially women with increased headaches or moodiness, were more likely to discontinue the OC prematurely. Nonetheless, most discontinuation occurred for reasons that were unrelated to side effects.
Conclusion:
Side effects are absent or mild among most OC users, but women with complaints are more likely to discontinue. Side effects are less important reasons for discontinuation than widely believed.
Related Concept Videos
Birth Control Methods
Effects of Chemicals: Overview
Intrauterine Drug Delivery Systems
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Menopause
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
